Skip to Content

WPI 3173 (Alendronate Sodium 70 mg)

Pill with imprint WPI 3173 is White, Capsule-shape and has been identified as Alendronate Sodium 70 mg. It is supplied by Watson Pharmaceuticals.

Alendronate is used in the treatment of osteoporosis; prevention of osteoporosis; paget's disease and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Alendronate 70 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 3173

Alendronate sodium 70 mg WPI 3173
Alendronate sodium 70 mg WPI 3173
Alendronate sodium 70 mg WPI 3173

Alendronate Sodium

Imprint
WPI 3173
Strength
70 mg
Color
White
Size
13.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Bisphosphonates
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals
National Drug Code (NDC)
00591-3173
Inactive Ingredients
magnesium stearate, mannitol, microcrystalline cellulose, sodium starch glycolate type A potato, corn starch

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "WPI 3173"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.